
Drugs for Neglected Diseases initiative
@dndi
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.
bsky.app/profile/dndi.o…
ID: 256440168
https://dndi.org 23-02-2011 09:59:25
12,12K Tweet
24,24K Followers
2,2K Following



Join Drugs for Neglected Diseases initiative & @PATHTweets at World Health Summit Regional Meeting 2025 for a panel discussion on Leveraging Artificial Intelligence for Transformative Drug Discovery and Development. Discover how AI is transforming R&D & expanding access to life-saving treatments. 🔗Register now: tinyurl.com/mwy3myw5


Our very own Michelle Childs discusses how this week's landmark WHO pandemic agreement could ensure public funding leads to public benefit - very informative piece by Sara Nolen in The New York Times nytimes.com/2025/04/16/hea…

In Turkana County, most #mycetoma patients are ostracized, treated as cursed or contagious. Children miss school because of stigma associated with the disease. Drugs for Neglected Diseases initiative goal is to develop new treatments that can prevent amputation & disability. Samwel Doe ouma➡️bit.ly/42AnUJb


A #ClinicalTrial is underway in Liverpool to advance a new oral treatment for #VisceralLeishmaniasis — one of the world’s deadliest parasitic diseases. Together with NHS University Hospitals of Liverpool Group & University of Liverpool, we’re testing a promising new drug: DNDI-6899. Wellcome 🔗 bit.ly/447sGyN


Drugs for Neglected Diseases initiative and partners have initiated clinical trials testing a new, easier-to-administer, & patient-friendly form of a medicine used to treat cryptococcal meningitis, which is a major health threat to people with weakened immune systems, including those with advanced HIV disease.

On the last day of World Health Summit Regional Meeting 2025, Drugs for Neglected Diseases initiative & PATH brought together voices across industry and acedemia to explore how AI can drive transformative drug discovery & ensure equitable access to life-saving treatments.





.Drugs for Neglected Diseases initiative, the National Health Service University Hospitals of Liverpool Group, and the University of Liverpool have initiated a clinical trial in Liverpool, United Kingdom to test an oral drug for visceral leishmaniasis, one of the world’s deadliest parasitic diseases.